Cosmos Health (COSM) Restructuring Costs (2021 - 2026)
Cosmos Health's (COSM) quarterly Restructuring Costs came in at $1.5 million in Q2 2026, up 69.83% on a YoY basis from $887465.0 in Q2 2025, and up 19.2% quarter-over-quarter from $1.3 million in Q1 2026.
Analysis
Cosmos Health (COSM) Restructuring Costs (2021 - 2026) Analysis & Trends
Cosmos Health (COSM) has reported Restructuring Costs for 4 consecutive years, with $1.5 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Restructuring Costs rose 69.83% year-over-year to $1.5 million; the trailing twelve-month figure through Jun 2026 stood at $18.3 million (up 108.78% YoY), and the FY2025 full-year result was $15.6 million, up 121.68% from the prior year.
- Restructuring Costs improved to $1.5 million in Q2 2026 per COSM's latest filing, from $1.3 million in the prior quarter.
- Across five years, Restructuring Costs topped out at $15.6 million in Q4 2025 and bottomed at $231750.0 in Q1 2024.
- Historically, Restructuring Costs has averaged $3.9 million across 3 years, with a median of $1.3 million in 2026.
- The sharpest annual moves came in 2025 and 2026: Restructuring Costs jumped 297.88% in 2025, then surged 37.12% in 2026.
- Over 3 years, Restructuring Costs stood at $7.0 million in 2024, then surged by 123.2% to $15.6 million in 2025, then tumbled by 90.32% to $1.5 million in 2026.
- According to Business Quant data, Restructuring Costs over the past three periods registered $1.5 million, $1.3 million, and $15.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.33 Bn | 38.68 Bn | 2.15 Bn |
| 2 | Viatris | 19.05 Bn | 18.16 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.76 Bn | 9.58 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.38 Bn | 5.25 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.27 Bn | 436.38 Mn | 2.10 Bn |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.51 Bn | 1.15 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 1.03 Bn | 737.26 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 393.12 Mn | 351.87 Mn | 17.15 Mn |
| 10 | Cosmos Health | 15.08 Mn | 12.63 Mn | 1.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.51 Mn |
| Mar 31, 2026 | 1.26 Mn |
| Dec 31, 2025 | 15.57 Mn |
| Jun 30, 2025 | 887,465.00 |
| Mar 31, 2025 | 922,090.00 |
| Dec 31, 2024 | 6.98 Mn |
| Mar 31, 2024 | 231,750.00 |
| Jun 30, 2021 | 578,598.00 |